For the first time ever in America, a birth control pill will be available over the counter. In July 2023, the Food and Drug Administration approved Opill, a progestin-only form of daily oral contraception. This move could open the doors to millions of people who need, and want, to use birth control. To understand the court rulings that got us here, the potential obstacles to equal access, and what Opill means for the future of contraceptives in the US, host Jonquilyn Hill speaks with Dr. Raegan McDonald-Mosley, an OBGYN and the CEO of Power to Decide, and Khiara M. Bridges, a professor of law at UC Berkeley School of Law. Learn more about your ad choices. Visit podcastchoices.com/adchoices

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related